Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Fintel reports that on November 10, 2025, B. Riley Securities reiterated coverage of Novavax (NasdaqGS:NVAX) with a Buy ...

Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...

BioNTech/Comirnaty Covid-19 vaccines are currently available. Read more at straitstimes.com. Read more at straitstimes.com.

The post Market Analysis: November 13th, 2025 appeared first on Stock Target Advisor.

Analysts also weigh in on Chesapeake Utilities, Halozyme Therapeutics, Sea Ltd., and Roper Technologies. Trump reverses on tariffs for some imports, Bitcoin falls on details of strategic reserve, ...

Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: ...

TAIPEI (Taiwan News) — Taiwan's Centers for Disease Control said Tuesday that 101,100 people sought emergency room treatment for flu-like illness last week, a 7.5% decrease from the previous week.

Detailed price information for Revolution Medicines Inc (RVMD-Q) from The Globe and Mail including charting and trades.

While most BioSpace LinkedIn poll respondents believe the job market won’t improve until at least 2027, two industry experts ...

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

The global vaccines market is projected to grow from USD 50.46 billion in 2025 to USD 63.66 billion by 2030, achieving a CAGR ...